TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Ramelteon 8 mg Tablets in collaboration with i3 Pharmaceuticals, LLC. The FDA-approved product is a generic equivalent to the ROZEREM® branded product. i3 is supplying this item to TruPharma pursuant to an exclusive Sales, Marketing & Distribution Agreement entered earlier this year.